PRIME MEDICINE INC
(NASDAQ: PRME)

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

6.735

+0.075 (+1.13%)
Range 6.620 - 7.130   (7.70%)
Open -
Previous Close 6.660
Bid Price 13.880
Bid Volume 10
Ask Price 14.390
Ask Volume 12
Volume 536,223
Value -
Remark
Delayed prices. Updated at 16 May 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis